2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$9.94+$0.03 (+0.29%)
Price as of Jul 14, 2026 6:00 AM EDT- $2.5BMarket Cap
- 10.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$9.94+$0.03 (+0.29%)
Earnings Score
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -16.26% | ||
12-Month Momentum | -6.51% | ||
3-Month Risk Adjusted Momentum | -81.41% | ||
12-Month Risk Adjusted Momentum | -14.88% |
True Yield
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -1.10% | ||
Net Debt Paydown Yield | -22.39% |
Financial Health Score
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |